Rakuten Medical eyes U.S. market for its novel idea to conquer cancer
FROM THE PUBLISHER
Biotech startup Rakuten Medical is eyeing the U.S. market for its novel idea to conquer cancer — light illumination therapy.The treatment, based on photoimmunotherapy — a combination of drug administration and illumination with red light — has long been in development as part of its Alluminox platform.“We believe this could become a new platform for cancer treatment,” Minami Maeda, who became CEO of Rakuten Medical in July, said in a recent interview with The Japan…
Original reporting by The Japan Times. Some articles may require a subscription.